Analysis Links Sports Betting Legalization to Rise in Problem Gambling Diagnoses

The Sports Business Journal released findings in late June 2026 that examined fresh medical data on problem gambling diagnoses across multiple states, and those numbers revealed a clear pattern tied to legalization status. Diagnoses climbed more than 60 percent in places that had approved sports betting while they dropped 29 percent elsewhere, creating a stark contrast that observers have begun to track closely since the 2018 Supreme Court decision opened the door for expanded markets.

Key Data Points from the Report

Researchers pulled diagnosis rates from insurance claims and hospital records covering recent years, then compared results between states with active sportsbooks and those that kept betting illegal. The absolute numbers stayed modest overall, yet the directional shift stood out because it aligned so precisely with where betting became accessible. In legalized states the rate reached 4.8 diagnoses per 100,000 residents, whereas non-legalized states recorded 2.2 per 100,000, according to the compiled figures.

Young adults drove much of the increase. Among people aged 18 to 29 the diagnosis rate doubled in states that legalized sports betting, a change that stood apart from other age groups and from trends in states that maintained restrictions. This age-specific spike appeared consistently across the datasets reviewed by the analysis team.

State-by-State Patterns Emerge

States that moved quickly after the 2018 ruling showed the steepest climbs once sportsbooks opened and advertising campaigns rolled out. Markets with widespread mobile betting apps and prominent television commercials recorded the largest year-over-year jumps, while neighboring states that held back on legalization continued to post declines. The analysis grouped states into two clear cohorts and tracked diagnosis counts month by month, revealing that the divergence widened as more platforms launched in the legalized group.

One study revealed that the timing of these increases matched the rollout schedules of major operators, with spikes appearing within the first full year after legalization in several jurisdictions. Observers note that the data does not establish direct causation, but the correlation has prompted health agencies to request additional funding for screening programs in the affected states.

Age Group Breakdown and Advertising Exposure

The doubling among 18-to-29-year-olds drew particular attention because this cohort already represents the heaviest users of mobile sports betting platforms. Data shows that daily active users in this age range grew rapidly once apps became available, and the same group accounts for a disproportionate share of the new diagnoses. Researchers cross-referenced advertising spend figures with diagnosis records and found that markets with heavier digital and broadcast promotions experienced faster growth in reported cases.

States without legalization avoided these advertising channels entirely, and their diagnosis rates continued the downward trend that had begun before 2018. The 29 percent drop in those states suggests that reduced visibility and fewer access points may have contributed to lower identification rates, though experts caution that other public health factors could also play a role.

Broader Context in June 2026

By June 2026 more than two dozen states had active sports betting markets, and the cumulative effect on healthcare systems is now measurable through the aggregated claims data. Hospitals and mental health providers in legalized states reported higher volumes of intake assessments related to gambling, while facilities in restricted states saw stable or reduced caseloads. The analysis from Sports Business Journal placed these trends alongside handle and revenue numbers to illustrate how market expansion and health indicators moved in tandem.

Public health departments have started to share preliminary screening results with state regulators, and several legislatures have scheduled hearings to review the findings. The report itself stops short of policy recommendations, yet the raw numbers have already circulated among lawmakers who track both tax revenue and social service costs.

Conclusion

The June 2026 analysis supplies one of the first large-scale comparisons of diagnosis trends since widespread legalization began, adn the patterns it uncovered remain consistent across multiple data sources. Absolute rates continue to sit at low levels nationally, yet the divergence between legalized and non-legalized states provides a measurable signal for ongoing monitoring. Further updates are expected as additional quarters of claims data become available and as more states finalize their regulatory frameworks.